Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Intravenous Lidocaine Decrease the Minimal Inducing Dose of Etomidate?: A Randomized Placebo-controlled Dose-response Study.

NCT01916642 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT01916642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01916642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Intravenous Lidocaine Decrease the Minimal Inducing Dose of Etomidate?: A Randomized Placebo-controlled Dose-response Study.
Lead sponsor
West China Hospital
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2013
Completion date
July 31, 2013
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

etomidate overdose of undetermined intent